A new trading day began on Friday, with Guardant Health Inc (NASDAQ: GH) stock price up 3.35% from the previous day of trading, before settling in for the closing price of $31.93. GH’s price has ranged from $15.81 to $41.06 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 49.27% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 24.85%. With a float of $115.97 million, this company’s outstanding shares have now reached $121.63 million.
In an organization with 1779 employees, it is important to assess its efficiency.
Guardant Health Inc (GH) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Diagnostics & Research Industry. The insider ownership of Guardant Health Inc is 5.23%, while institutional ownership is 93.69%. The most recent insider transaction that took place on Jun 04 ’24, was worth 2,787. In this transaction Director of this company sold 100 shares at a rate of $27.87, taking the stock ownership to the 4,621 shares. Before that another transaction happened on Mar 18 ’24, when Company’s Chief Information Officer bought 2,187 for $17.82, making the entire transaction worth $38,963. This insider now owns 12,722 shares in total.
Guardant Health Inc (GH) Latest Financial update
In its latest quarterly report, released on 3/31/2024, the company reported earnings of -0.67 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.73 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 24.85% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.20% during the next five years compared to -8.88% drop over the previous five years of trading.
Guardant Health Inc (NASDAQ: GH) Trading Performance Indicators
Here are Guardant Health Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.66. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.69.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.92, a number that is poised to hit -0.74 in the next quarter and is forecasted to reach -2.80 in one year’s time.
Technical Analysis of Guardant Health Inc (GH)
Let’s dig in a bit further. During the last 5-days, its volume was 0.93 million. That was inferior than the volume of 1.94 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 50.69%. Additionally, its Average True Range was 1.57.
During the past 100 days, Guardant Health Inc’s (GH) raw stochastic average was set at 94.11%, which indicates a significant increase from 86.05% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 56.93% in the past 14 days, which was lower than the 66.56% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $28.97, while its 200-day Moving Average is $24.20. However, in the short run, Guardant Health Inc’s stock first resistance to watch stands at $33.75. Second resistance stands at $34.51. The third major resistance level sits at $35.48. If the price goes on to break the first support level at $32.02, it is likely to go to the next support level at $31.05. The third support level lies at $30.29 if the price breaches the second support level.
Guardant Health Inc (NASDAQ: GH) Key Stats
With a market capitalization of 4.04 billion, the company has a total of 122,369K Shares Outstanding. Currently, annual sales are 563,950 K while annual income is -479,450 K. The company’s previous quarter sales were 168,490 K while its latest quarter income was -114,990 K.
